search button
Open Access

LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer

  • Authors:
    • Yonghong Zhang
    • Huamin Li
    • Wenyong Zhang
    • Ya Che
    • Weibing Bai
    • Guanglin Huang

  • View Affiliations

  • Published online on: October 22, 2018     https://doi.org/10.3892/mmr.2018.9567
  • Pages: 5579-5593

  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to identify a long non‑coding (lnc) RNAs‑based signature for prognosis assessment in gastric cancer (GC) patients. By integrating gene expression data of GC and normal samples from the National Center for Biotechnology Information Gene Expression Omnibus, the EBI ArrayExpress and The Cancer Genome Atlas (TCGA) repositories, the common RNAs in Genomic Spatial Event (GSE) 65801, GSE29998, E‑MTAB‑1338, and TCGA set were screened and used to construct a weighted correlation network analysis (WGCNA) network for mining GC‑related modules. Consensus differentially expressed RNAs (DERs) between GC and normal samples in the four datasets were screened using the MetaDE method. From the overlapped lncRNAs shared by preserved WGCNA modules and the consensus DERs, an lncRNAs signature was obtained using L1‑penalized (lasso) Cox‑proportional hazard (PH) model. LncRNA‑mRNA networks were constructed for these signature lncRNAs, followed by functional annotation. A total of 14,824 common mRNAs and 2,869 common lncRNAs were identified in the 4 sets and 5 GC‑associated WGCNA modules were preserved across all sets. MetaDE method identified 1,121 consensus DERs. A total of 50 lncRNAs were shared by preserved WGCNA modules and the consensus DERs. Subsequently, an 11‑lncRNA signature was identified by LASSO‑based Cox‑PH model. The lncRNAs signature‑based risk score could divide patients into 2 risk groups with significantly different overall survival and recurrence‑free survival times. The predictive capability of this signature was verified in an independent set. These signature lncRNAs were implicated in several biological processes and pathways associated with the immune response, the inflammatory response and cell cycle control. The present study identified an 11‑lncRNA signature that could predict the survival rate for GC.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 18 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 7.6
  • CiteScore Rank: Q1: #82/347 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.647
  • SCImago Journal Rank (SJR): 0.781
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Li H, Zhang W, Che Y, Bai W and Huang G: LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer. Mol Med Rep 18: 5579-5593, 2018
APA
Zhang, Y., Li, H., Zhang, W., Che, Y., Bai, W., & Huang, G. (2018). LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer. Molecular Medicine Reports, 18, 5579-5593. https://doi.org/10.3892/mmr.2018.9567
MLA
Zhang, Y., Li, H., Zhang, W., Che, Y., Bai, W., Huang, G."LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer". Molecular Medicine Reports 18.6 (2018): 5579-5593.
Chicago
Zhang, Y., Li, H., Zhang, W., Che, Y., Bai, W., Huang, G."LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer". Molecular Medicine Reports 18, no. 6 (2018): 5579-5593. https://doi.org/10.3892/mmr.2018.9567